Filing Details
- Accession Number:
- 0000885590-12-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-08 19:00:42
- Reporting Period:
- 2012-03-06
- Filing Date:
- 2012-03-08
- Accepted Time:
- 2012-03-08 19:00:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1536053 | Bradley Howard Schiller | 7150 Mississauga Road Mississauga A6 L5N 8M5 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2012-03-06 | 9,200 | $53.53 | 136,800 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price. Purchases were made in the range of $53.25 to $53.95.
- This number includes common shares purchased by the officer and restricted share units that were previously reported in Table 1.